v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net loss $ 509 $ (4,719) $ (6,016) $ (7,962)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization of debt premium, discount and issuance cost     (22) 1,246  
Provision for credit losses     (2) (122)  
Paid-in-kind accrual on short-term debt     0 150  
Changes in deferred tax assets and liabilities     679 (31)  
Change in allowance for sales returns and volume rebates     58 (837)  
Change in fair value of common warrants 0 251 0 (1,685)  
Change in inventory reserve     95 (686)  
Change in fair value of derivative liabilities 122 42 154 51  
Stock compensation expense     212 348  
Depreciation and amortization     5,133 5,054  
Loss on warrant issuance 0 0 0 578  
Change in right of use assets and lease liabilities     (325) (197)  
Changes in operating assets and liabilities:          
Accounts receivable – trade     (405) (2,311)  
Inventories     4,727 14,712  
Prepaid expenses and other current assets     (2,099) (41)  
Other assets     (164) 55  
Accounts payable and accrued expenses     (8,616) (13,452)  
Other short-term liabilities     251 (134)  
Other liabilities     49 165  
Deferred revenues     (1,181) (748)  
Net cash used in operating activities     (7,472) (5,847)  
Cash flows from investing activities:          
Purchases of furniture and fixtures, net     (75) (159)  
Net cash used in investing activities     (75) (159)  
Cash flows from financing activities:          
Proceeds from short-term debt     0 2,500  
Principal payments on short-term debt     0 (2,010)  
Net change in related party accounts payable-inventory financing     (577) 2,747 $ 3,699
Proceeds from issuance of common stock and pre-funded warrants     3,682 2,818  
Net cash provided by financing activities     3,105 6,055  
Effect of foreign currency exchange rates     (626) (448)  
Net decrease in cash and cash equivalents     (5,068) (399)  
Cash and cash equivalents, beginning of the period     9,370 8,007 8,007
Cash and cash equivalents, end of the period 4,302 7,608 4,302 7,608 $ 9,370
Supplemental cash flow disclosures:          
Cash paid for income taxes     79 706  
Cash paid for interest     1,743 3,431  
Non-cash investing and financing transactions:          
Addition of operating lease liabilities     186 0  
Cash dividends accrued for Series B Preferred stockholders $ 634 $ 634 634 634  
Conversion of convertible related-party debt to common stock     $ 556 $ 0